AZTA
NASDAQ
US
Azenta, Inc. - Common Stock
$22,63
▲ +$1,45
(+6,85%)
Vol 1.1M
5
Skor Kualitas
fail
Pendapatan ✗
Laba Bersih ✗
>IPO ✗
Kap. Pasar
$1.5B
ROE
-3,3%
Margin
-9,4%
D/E
0,09
Beta
1,35
52W
$24–$56
Konsensus Wall Street
14 analis · Apr 20263
Beli Kuat
6
Beli
5
Tahan
0
Jual
0
Jual Kuat
64,3%
Peringkat Beli
Grafik Harga
Saham Serupa
SHC
Sotera Health Co
P/E 90,4
$5.0B
TXG
10X Genomics Inc
$2.1B
ADPT
Adaptive Biotechnologies Corp
$2.5B
BLFS
BioLife Solutions Inc
$1.2B
FTRE
Fortrea Holdings Inc
$1.6B
PSNL
Personalis Inc
$706.9M
CTKB
Cytek Biosciences Inc
$645.7M
MLAB
Mesa Laboratories Inc
$433.5M
CYRX
Cryoport Inc
P/E 7,1
$480.7M
Pendapatan
Tingkat beat: 50,0%| Kuartal | EPS Estimasi | EPS Aktual | Kejutan |
|---|---|---|---|
| Des 2025 | $0,14 | $0,09 | $-0,05 |
| Sep 2025 | $0,19 | $0,21 | +$0,02 |
| Jun 2025 | $0,14 | $0,19 | +$0,05 |
| Mar 2025 | $0,07 | $0,05 | $-0,02 |
Pendapatan & Laba Kuartalan
| Kuartal | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Pendapatan | — | $147.4M | $143.4M | $143.9M | $159.0M | $148.6M |
| Laba Bersih | — | -$11.0M | -$40.5M | -$52.8M | $50.8M | -$15.4M |
Tren Fundamental
| Metrik | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -6.5% | -6.5% | -6.5% | -6.5% | -6.5% | -3.3% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -36.7% | -18.4% | -18.4% | -18.4% | -18.4% | -9.4% |
| Gross Margin | 47.1% | 44.9% | 44.9% | 44.9% | 44.9% | 45.5% |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.09 |
| Current Ratio | 2.76 | 2.76 | 2.76 | 2.76 | 2.76 | 2.98 |
Rasio Utama
ROA (TTM)
-2,7%
P/S (TTM)
2,58
P/B
0,8
EPS (TTM)
$-1,22
CF/Share
$1,10
Pertumbuhan Pendapatan 3T
+2,3%
52W High
$55,64
52W Low
$23,91
$23,91
Rentang 52 Minggu
$55,64
Kesehatan Keuangan
Arus Kas Bebas
$14.7M
Utang Bersih
-$282.2M
Kas
$336.6M
Total Utang
$54.5M
Per tanggal Des 31, 2025
Як AZTA виглядає на тлі конкурентів у Life Sciences Tools & Services?
Група порівняння: Small-cap Life Sciences Tools & Services ($300M+) · 25 компаній
Оцінка AZTA vs аналоги Life Sciences Tools & Services
P/E
—
▼
0%
di bawah
rekan
(32,5)
vs Rekan
vs Industri
Nilai wajar
P/S
2,6
▼
33%
di bawah
rekan
(3,8)
vs Rekan
vs Industri
Lebih mahal
P/B
0,8
▼
80%
di bawah
rekan
(3,7)
vs Rekan
vs Industri
Undervalued
Дивідендна дохідність
—
▼
0%
di bawah
rekan
(0,5%)
vs Rekan
vs Industri
Yield rendah
Прибутковість AZTA vs аналоги Life Sciences Tools & Services
ROE
-3,3%
▲
0%
di atas
rekan
(-3,3%)
vs Rekan
vs Industri
Sejajar
Net margin
-9,4%
▲
0%
di atas
rekan
(-9,4%)
vs Rekan
vs Industri
Sejajar
Валова маржа
45,5%
▼
5%
di bawah
rekan
(48,0%)
vs Rekan
vs Industri
Lemah
ROA
-2,7%
▼
5%
di bawah
rekan
(-2,6%)
vs Rekan
vs Industri
Sejajar
Фінансове здоровʼя AZTA vs аналоги Life Sciences Tools & Services
D/E ratio
0,1
▼
100%
di bawah
rekan
(36,5)
vs Rekan
vs Industri
Utang rendah
Поточна ліквідність
3,0
▼
12%
di bawah
rekan
(3,4)
vs Rekan
vs Industri
Sejajar
Beta
1,4
▼
5%
di bawah
rekan
(1,4)
vs Rekan
vs Industri
Kurang volatil
Радар фундаменталів AZTA
AZTA
Median rekan
Industri
AZTA прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
AZTA vs аналоги: ключові метрики
Aktivitas Orang Dalam
NeutralPembelian
0
Penjualan
0
NOVA TINA SUSAN
Director · Feb 06
5663 shs
DOSHI DIPAL
Director · Feb 05
5663 shs
MCLAUGHLIN ERICA
Director · Feb 05
5663 shs
CASAL FRANK
Director · Feb 05
7243 shs
Terakhir 90 hari
Pemegang Terbesar
Top 5: 43,2%Blackrock Inc.
14,72%
$134.9M
Politan Capital Management …
10,02%
$91.9M
Vanguard Group Inc
9,85%
$90.3M
Dimensional Fund Advisors LP
4,56%
$41.8M
Millennium Management Llc
4,05%
$37.1M
Per tanggal Des 31, 2025
Dividen
$0,40
/ tahun
Des 02, 2021
$0,1000
Sep 02, 2021
$0,1000
Jun 03, 2021
$0,1000
Mar 04, 2021
$0,1000
Des 03, 2020
$0,1000
Sep 03, 2020
$0,1000
Jun 04, 2020
$0,1000
Mar 05, 2020
$0,1000
Berita Terbaru
Belum ada berita terkait